NCT06928298 Cognitive Screening Made Easy for PCPs - Administrative Supplement
| NCT ID | NCT06928298 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-06-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-06-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.
Eligibility Criteria
Inclusion Criteria: * Inclusion Criteria: * Aged 60 years and older; * Ethnic/racial background consistent with NIH policy * Male or female * Fluent in Spanish. Exclusion Criteria: * Confounding conditions that could impact ability to participate in the study (e.g., cognitive impairment sufficient to impact ability to follow instructions on the iPad, motor impairment that would prohibit independent use of RACS, poor visual acuity) * Prior diagnosis of dementia * Non-Spanish speaking.
Contact & Investigator
Robin C Hilsabeck, PhD
PRINCIPAL INVESTIGATOR
University of Texas Health Sciences Center at San Antonio
Frequently Asked Questions
Who can join the NCT06928298 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06928298 currently recruiting?
Yes, NCT06928298 is actively recruiting participants. Contact the research team at hilsabeck@uthscsa.edu for enrollment information.
Where is the NCT06928298 trial being conducted?
This trial is being conducted at Austin, United States, Austin, United States, San Antonio, United States.
Who is sponsoring the NCT06928298 clinical trial?
NCT06928298 is sponsored by University of Texas at Austin. The principal investigator is Robin C Hilsabeck, PhD at University of Texas Health Sciences Center at San Antonio. The trial plans to enroll 100 participants.